PINC Technologies, a Caltech spinout developing advanced integrated nonlinear photonic devices and circuits, announced the close of its Seed+ financing round, bringing total funds raised to date to $6.8 million. The funding marks a major milestone for the young company…
CytoAgents, Inc., a clinical-stage biotechnology company focused on developing safe and effective preventative therapies for life-threatening immune-related toxicities, today announced it has been awarded a $2.25 million grant from the National Institutes of Health (NIH). This grant, issued through the…
Predicta Biosciences, a precision oncology company pioneering next-generation diagnostic and therapeutic discovery solutions, today announced the successful close of a $23.4 million oversubscribed Series A financing round. The investment was led by Engine Ventures, with strong participation from Illumina Ventures,…